These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14971119)

  • 21. [PPI-test].
    Takahashi M; Katayama Y; Suzuki K; Tajima A; Oka S; Koizumi K; Ichimura H; Kuwayama H
    Nihon Rinsho; 2007 May; 65(5):852-63. PubMed ID: 17511224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of gastro-oesophageal reflux disease in primary care: a European observational study.
    Gisbert JP; Cooper A; Karagiannis D; Hatlebakk J; Agréus L; Jablonowski H; Tafalla M
    Curr Med Res Opin; 2009 Nov; 25(11):2777-84. PubMed ID: 19785512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid suppressive therapy use on an inpatient internal medicine service.
    Pham CQ; Regal RE; Bostwick TR; Knauf KS
    Ann Pharmacother; 2006; 40(7-8):1261-6. PubMed ID: 16804095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous proton pump inhibition utilization and prescribing patterns escalation: a comparison between early and current trends in use.
    Law JK; Andrews CN; Enns R
    Gastrointest Endosc; 2009 Jan; 69(1):3-9. PubMed ID: 18718583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Refractory GERD": acid, nonacid, or not GERD?
    Vaezi MF
    Am J Gastroenterol; 2004 Jun; 99(6):989-90. PubMed ID: 15180714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
    Noar MD; Lotfi-Emran S
    Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
    Bardhan KD; Berghöfer P
    Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.
    Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
    Aliment Pharmacol Ther; 2007 Mar; 25(6):715-22. PubMed ID: 17311605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acid-related disease in the population of two Norwegian municipalities--diagnosis and drug therapy].
    Vetvik K; Straand J
    Tidsskr Nor Laegeforen; 2001 Feb; 121(5):557-62. PubMed ID: 11301609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the treatment of GERD in the elderly: focus on proton pump inhibitors.
    Pilotto A; Franceschi M; Paris F
    Int J Clin Pract; 2005 Oct; 59(10):1204-9. PubMed ID: 16178989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitor utilization patterns in infants.
    Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic strategies for treating gastroesophageal reflux disease.
    Vivian EM; Thompson MA
    Clin Ther; 2000 Jun; 22(6):654-72. PubMed ID: 10929915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications and antireflux medication use after antireflux surgery.
    Dominitz JA; Dire CA; Billingsley KG; Todd-Stenberg JA
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):299-305. PubMed ID: 16527692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use.
    Targownik LE; Metge C; Roos L; Leung S
    Am J Gastroenterol; 2007 May; 102(5):942-50. PubMed ID: 17313495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD).
    Maceri DR; Zim S
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1976-9. PubMed ID: 11801981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.
    Shireman TI; Rigler SK
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):210-8. PubMed ID: 17062321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.